Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin.
Inactivation of pulmonary surfactant by different components such as serum, cholesterol or meconium contributes to severe respiratory pathologies through destabilization and collapse of airspaces. Recent studies have analyzed in detail how the interfacial properties of natural surfactant purified fr...
Main Authors: | Yuliannis Lugones, Odalys Blanco, Elena López-Rodríguez, Mercedes Echaide, Antonio Cruz, Jesús Pérez-Gil |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6147439?pdf=render |
Similar Items
-
In vitro activity of the clinical pulmonary surfactant Surfacen® against Leishmania amazonensis
by: Odalys Blanco, et al.
Published: (2011-08-01) -
Spreading kinetics of the exogenous porcine surfactant Surfacen® mixed with drugs used in respiratory clinics
by: Odalys Blanco, et al. -
Human neutrophil elastase and lung surfactant in acute respiratory distress syndrome
by: Odalys Blanco, et al. -
Pulmonary Surfactant and Drug Delivery: An Interface-Assisted Carrier to Deliver Surfactant Protein SP-D Into the Airways
by: Cristina García-Mouton, et al.
Published: (2021-01-01) -
Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome.
by: Chiara Autilio, et al.
Published: (2018-01-01)